Skip to main content
Jessica Walters on Muck Rack

Jessica Walters

As seen in: Nature, EIN News, Psychiatric Times, Tatler Asia

Get in touch with Jessica

Contact Jessica, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days - Scientific Reports

|
By R. Nathan Pipitone, Benjamin Banai, Jessica Walters, Martha Rosenthal, Kevin Provost, Keenan Keeling, Tyler Dautrich, Kelly Schuller, Branden Hall
| Nature Verified
Abstract Previous research has shown medical cannabis (MC) to help reduce anxiety for some individuals, although most studies show trends using cross-sectional designs or conduct secondary analyses of preexisting data. The present study systematically tracked 416 registered MC patients in Florida across 45 days to assess daily shifts in anxiety levels.
Open in Who Shared Issue with article?

NDA Accepted and Priority Review Granted: Oveporexton for Narcolepsy Type 1

|
By Leah Kuntz Verified, Jessica Walters
| urldefense.com
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Open in Who Shared View Duplicates (679) Issue with article?

Dronabinol for Agitation in Autism Spectrum Disorder: Research From the National Update on Behavioral Emergencies Conference

|
By Jessica Walters
| EIN News
Marinol (dronabinol) was found to be a potentially beneficial treatment for patients with autism spectrum disorder (ASD) who are experiencing acute agitation in emergency care, from a study presented at the National Update on Behavioral Emergencies Conference in New Orleans, LA, December 8-10.1 While this may not be a first-line agent, Marinol may offer an adjunctive option for patients with ASD in emergency settings experiencing sensory overload, medication sensitivity, or are unresponsive...
Open in Who Shared View Duplicates (2) Issue with article?
See all 4 licensed articles (311 Total)